Arcturus Therapeutics Holdings (ARCT) Cash from Investing Activities Growth (1y) (2019 - 2026)
Arcturus Therapeutics Holdings (ARCT) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -114.28% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 826.39% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -674.01% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | 124.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.82% |
| Sep 30, 2025 | -126.25% |
| Mar 31, 2025 | 42.92% |
| Sep 30, 2024 | 91.85% |
| Jun 30, 2024 | 7.34% |
| Mar 31, 2024 | 65.27% |
| Dec 31, 2023 | 77.02% |
| Sep 30, 2023 | 55.12% |
| Jun 30, 2023 | -193.65% |
| Mar 31, 2023 | 67.27% |
| Dec 31, 2022 | -240.52% |
| Sep 30, 2022 | -23.78% |
| Jun 30, 2022 | 193.56% |
| Mar 31, 2022 | -1,688.98% |
| Dec 31, 2021 | -60.40% |
| Sep 30, 2021 | -306.91% |
| Jun 30, 2021 | 13.86% |
| Mar 31, 2021 | 16.90% |
| Dec 31, 2020 | -121.27% |
| Sep 30, 2020 | -172.96% |